TCG Crossover Management, LLC — 13F holdings

TCG Crossover Management, LLC reported 54 holdings worth $4.16B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. ABVX ABIVAX SA — $801M (19.2%)
2. TNGX TANGO THERAPEUTICS INC — $284M (6.8%)
3. CGON CG ONCOLOGY INC — $261M (6.3%)
4. COGT COGENT BIOSCIENCES INC — $188M (4.5%)
5. IMVT Immunovant Inc — $172M (4.1%)
6. SYRE SPYRE THERAPEUTICS INC — $169M (4.1%)
7. DNTH Dianthus Therapeutics Inc — $163M (3.9%)
8. MIRM MIRUM PHARMACEUTICALS INC — $124M (3.0%)
9. ZLAB ZAI LAB LTD — $117M (2.8%)
10. AMLX AMYLYX PHARMACEUTICALS INC — $112M (2.7%)